Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo

被引:32
作者
Braun, Benjamin S.
Archard, Joehleen A.
Van Ziffle, Jessica A. G.
Tuveson, David A.
Jacks, Tyler E.
Shannon, Kevin
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[3] MIT, Dept Biol, Cambridge, MA 02139 USA
关键词
D O I
10.1182/blood-2006-01-013490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Somatic activation of a conditional targeted Kras(G12D) allele induces a fatal myeloproliferative disease in mice that closely models juvenile and chronic myelomonocytic leukemia. These mice consistently develop severe and progressive anemia despite adequate numbers of clonogenic erythrold progenitors in the bone marrow and expanded splenic hematopoiesis. Ineffective erythropoiesis is characterized by impaired differentiation. These results demonstrate that endogenous levels of oncogenic Ras have cell lineage-specific effects and support efforts to modulate Ras signaling for therapy of anemia in patients with myelodysplastic syndromes and myeloproliferative disorders.
引用
收藏
页码:2041 / 2044
页数:4
相关论文
共 26 条
  • [1] Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
    Araki, T
    Mohi, MG
    Ismat, FA
    Bronson, RT
    Williams, IR
    Kutok, JL
    Yang, WT
    Pao, LI
    Gilliland, DG
    Epstein, JA
    Neel, BG
    [J]. NATURE MEDICINE, 2004, 10 (08) : 849 - 857
  • [2] THE GTPASE SUPERFAMILY - A CONSERVED SWITCH FOR DIVERSE CELL FUNCTIONS
    BOURNE, HR
    SANDERS, DA
    MCCORMICK, F
    [J]. NATURE, 1990, 348 (6297) : 125 - 132
  • [3] Bowen DT, 2002, BAS CLIN ON, V27, P345
  • [4] Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder
    Braun, BS
    Tuveson, DA
    Kong, N
    Le, DT
    Kogan, SC
    Rozmus, J
    Le Beau, MM
    Jacks, TE
    Shannon, KM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) : 597 - 602
  • [5] Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease
    Chan, IT
    Kutok, JL
    Williams, IR
    Cohen, S
    Kelly, L
    Shigematsu, H
    Johnson, L
    Akashi, K
    Tuveson, DA
    Jacks, T
    Gilliland, DG
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (04) : 528 - 538
  • [6] Mutant N-RAS induces erythroid lineage dysplasia in human CD34(+) cells
    Darley, RL
    Hoy, TG
    Baines, P
    Padua, RA
    Burnett, AK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07) : 1337 - 1347
  • [7] Downward J, 1996, CANCER SURV, V27, P87
  • [8] EMANUEL PD, 1991, BLOOD, V77, P925
  • [9] Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7
    Hasle, H
    Aricò, M
    Basso, G
    Biondi, A
    Rajnoldi, AC
    Creutzig, U
    Fenu, S
    Fonatsch, C
    Haas, OA
    Harbott, J
    Kardos, G
    Kerndrup, G
    Mann, G
    Niemeyer, CM
    Ptoszkova, H
    Ritter, J
    Slater, R
    Stary, J
    Stollmann-Gibbels, B
    Testi, AM
    van Wering, ER
    Zimmermann, M
    [J]. LEUKEMIA, 1999, 13 (03) : 376 - 385
  • [10] A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin plus granulocyte colony-stimulating factor:: significant effects on quality of life
    Hellström-Lindberg, E
    Gulbrandsen, N
    Lindberg, G
    Ahlgren, T
    Dahl, IMS
    Dybedal, I
    Grimfors, G
    Hesse-Sundin, E
    Hjorth, M
    Kanter-Lewensohn, L
    Linder, O
    Luthman, M
    Löfvenberg, E
    Öberg, G
    Porwit-MacDonald, A
    Rådlund, A
    Samuelsson, J
    Tangen, JM
    Winquist, I
    Wisloff, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) : 1037 - 1046